VENUE FOR UNIFIED LICENSING SEMINAR (ULS-NCR) ON 18 AND 21 JUNE 2019 AND CENTER FOR DEVICE REGULATION, RADIATION HEALTH AND RESEARCH QPIRA SEMINAR (QCDRRHR – NCR) ON 19-20 JUNE 2019
Please be informed that the venue for the Unified Licensing Seminar (ULS – NCR) on 18 & 21 June 2019 and Center for Device Regulation, Radiation Health and Research QPIRA […]
FDA Advisory No. 2019-153-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Napatunayang Pekeng Bersyon ng Drug Speeda Rabies Vaccine
to continue reading, click the attachment below… Attachment-> :FDA Advisory No. 2019-153-A
FDA Advisory No. 2019-153 || Public Health Warning Against the Purchase and Use of the Verified Counterfeit Version of Drug Speeda Rabies Vaccine
to continue reading, click the attachment below… Attachment-> : FDA Advisory No. 2019-153
FDA Advisory No. 2019-152-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Napatunayang Pekeng Bersyon ng ANTI-RABIES SERUM (EQUINE) EQUIRAB 5mL Vial
to continue reading, click the attachment below… Attachment-> :FDA Advisory No. 2019-152-A
FDA Advisory No. 2019-152 || Public Health Warning Against the Purchase and Use of the Verified Counterfeit Version of ANTI-RABIES SERUM (EQUINE) EQUIRAB 5mL Vial
to continue reading, click the attachment below… Attachment-> : FDA Advisory No. 2019-152
FDA Advisory No. 2019-154 || INTERNET SALES AND ACCESS TO SAFE MEDICINE
The Food and Drug Administration (FDA) warns the public on significant risks associated with the growth of the internet’ sales of medicines. Unlike other consumer products purchased over the internet, […]
FDA Advisory No. 2019-151-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Napatunayang Pekeng Bersyon ng Gamot na Co-Amoxiclav (Augmentin) Powder for Oral Suspension.
Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng napatunayang pekeng bersyon ng gamot na Co-Amoxiclav (Augmentin) Powder for Oral Suspension. Ayon sa pagsusuri […]
FDA Advisory No. 2019-151 || Public Health Warning Against the Purchase and Use of the Verified Counterfeit Version of Drug Product Co-Amoxiclav (Augmentin) Powder for Oral Suspension
The Food and Drug Administration (FDA) advises the public against the purchase and use of the verified counterfeit version of drug product Co-Amoxiclav (Augmentin) Powder for Oral Suspension. The FDA, […]
FDA Advisory No. 2019-150-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Hindi Rehistradong Gamot na:
Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga hindi rehistradong gamot na: Keteling Jiaonang YANYAN PIAN Tablet YIN HUANG JIAO NANG QINGFEI […]
FDA Advisory No. 2019-150 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:
The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products: Keteling Jiaonang YANYAN PIAN Tablet YIN HUANG JIAO NANG QINGFEI […]